Essential Oral Single Nutritional Therapy Products for Inherited Metabolic Diseases: Evidence and Consensus Assessment Using a Modified Delphi Method
Journal of Inherited Metabolic Disease · 2026
DOI: 10.1002/jimd.70252 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von Nina N Stolwijk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medicines for Society (Medicijn voor de Maatschappij), Platform at Amsterdam UMC-University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Metabolic Diseases, Dietary Supplements, Nutrition Therapy, Metabolism, Inborn Errors. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postcodeloterij..
Abstract (Originalsprache)
Nutritional therapy is critical in managing inherited metabolic diseases (IMDs), and includes specialized diets and single nutritional therapy products (sNTPs) such as vitamins, cofactors, and amino acids. Many sNTPs function as medicines, but are regulated as food (e.g., food supplements), which can limit access, reimbursement, and consistent supply. Essential medicines, as defined by World Health Organization (WHO), meet key healthcare needs and must be available, affordable, and quality‐assured. Some sNTPs might meet this threshold, supporting their potential inclusion in the WHO essential medicines list. A modified Delphi process was conducted with a panel of 36 experts from 18 European countries to identify which sNTPs are essential for IMD treatment. Ninety‐six sNTPs and their target IMDs were assessed using a literature‐informed five‐criteria framework, that included evaluation of the level of scientific evidence for usefulness and effectiveness. Overall, 31 sNTPs were deemed essential in the management of 55 IMDs, consisting of vitamins ( n = 12), minerals ( n = 4), amino acids ( n = 6), sugars ( n = 2), and other nutrients ( n = 7). Evidence supporting their use ranged from levels 3 to 4 of the Oxford Centre for Evidence‐Based Medicine (OCEBM), reflecting the limited clinical trial data inherent to rare diseases. Seven of these are already included in the WHO essential medicines list. Recognition of the remaining 24 essential sNTPs could improve their availability and reimbursement, and in some cases, may warrant formal authorization as medicines. Subsequent research should focus on access inequities, cost barriers, and incorporate patient perspectives to optimize the use and impact of sNTPs in IMD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicines for Society (Medicijn voor de Maatschappij), Platform at Amsterdam UMC-University of Amsterdam, Amsterdam, the Netherlands.
- Department of Endocrinology and Metabolism. Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Expertise Center for Inborn Errors of Metabolism, MetabERN, University of Amsterd…
- Department of Pediatrics, Division of Metabolic Diseases, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.
- Department of Laboratory Medicine, Laboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.
ORCID-Profile: Nina N Stolwijk, Bart M F Penninx, Annet M Bosch, Mirjam Langeveld, Carla E M Hollak
Förderung
- Postcodeloterij.
Zitieren
APA
Stolwijk, N. N., Penninx, B. M. F., Bosch, A. M., Langeveld, M., Salomons, G. S., Hollak, C. E. M., & Essential Nutritional Therapy Products for IMDs Consensus Group (2026). Essential Oral Single Nutritional Therapy Products for Inherited Metabolic Diseases: Evidence and Consensus Assessment Using a Modified Delphi Method. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70252
Vancouver
Stolwijk NN, Penninx BMF, Bosch AM, Langeveld M, Salomons GS, Hollak CEM, et al. Essential Oral Single Nutritional Therapy Products for Inherited Metabolic Diseases: Evidence and Consensus Assessment Using a Modified Delphi Method. Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70252
BibTeX
@article{Stolwijk2026,
author = {Stolwijk, Nina N and Penninx, Bart M F and Bosch, Annet M and Langeveld, Mirjam and Salomons, Gajja S and Hollak, Carla E M and Essential Nutritional Therapy Products for IMDs Consensus Group, Essential Nutritional Therapy Products for IMDs Consensus Group},
title = {Essential Oral Single Nutritional Therapy Products for Inherited Metabolic Diseases: Evidence and Consensus Assessment Using a Modified Delphi Method},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
doi = {10.1002/jimd.70252}
}
EUVIMED